Study Site

Houston, Texas 77095

1 studies enrolling now · 11 studies all time

What they study most

Acute Major Bleeding, Adolescent Schizophrenia, Blood Coagulation Disorders, CKD, Celiac Disease, Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features, Factor XIII Deficiency, Hemophilia A, Metabolic Acidosis, Reversal of Coagulopathy, Sickle Cell Anemia, Sickle Cell Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis — Recruiting now
• Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes — Completed
• Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease — Completed
• Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease — Completed
• An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A — Completed
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. — Stopped early
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes — Completed
• An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure — Completed
• Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy — Completed
• An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency — Completed
• A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. — Completed